|
|
 |
Archive
-
Title:
Adjuvant Chemotherapy in Elderly Patients with Breast Cancer
Date:
May 2010
Authors:
1. Early Breast Cancer Trialists' Collaborative Group. Effects of Chemotheraphy and hormonal theraphy for early breast cancer on recurrence and 15-year survival: an overview of randomized clinical trials. Lancet 2005; 365:1687-1717.
2. A. Goldhirsch, JN. Ingle, RD. Gelber, AS. Coates, B. Thurlimann, HJ. Senn. Thresholds for therapies: Highlights from the St. Gallen International Expert Consensus on the Primary Theraphy of Early Breast Cancer 2009. Ann Oncol 2009; 20: 1319-1329.
3. JA. Oshaughessney, J. Blum, V. Moiseyenko et al. Randomized, open- label phase-II- trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF as first-line treatment for advanced/metastatic breast cancer. Ann Oncol 2001; 12: 1247-1254.
4. HB. Muss, DA. Berry, PHD. Constance, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009; 360: 2055-2065.
Review by Prof. Hans Joerg Senn
More Details
|
-
Title:
Advanced breast cancer mortality in randomized controlled trials on mammography screening
Date:
May 2010
Authors:
Autier P., Hénry C., Haukka J., Boniol M., Byrnes J.J Cl Oncol 27:5919-5923, 2009
Review by Dr. Antonio Ponti
More Details
|
-
Title:
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast
Date:
October 2009
Authors:
E A Rakha, M Aleskandarany, M E El-Sayed, R W Blamey, C W Elston, I O Ellis and A H S Lee
European Journal of Cancer 2009; 45: 1780-1787
More Details
|
-
Title:
Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.
Date:
October 2009
Authors:
Gilbert FG, Warren, RMI, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO.
Radiology 2009;252:358-368
More Details
|
-
Title:
A multicenter radomized trial of breast intensity-modulated radiation therapy to reduce acute dermatitis.
Date:
March 2009
Authors:
Pignol J-P, Olivtto I, Rakovitch E. and Paszat L.
J Clin Oncol 2008; 26:2085-2092.
More Details
|
-
Title:
Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.
Date:
Aug. 5 2008
Authors:
D. Puliti, G. Miccinesi, N. Collina et al. (the IMPACT Working Group).
Br J Cancer 2008, 99(3): 423-427
More Details
|
|
|
|
|
-
Title:
Expression profiling technology: its contribution to our understanding of breast cancer.
Date:
July 2008
Authors:
E A Rakha, M E El-Sayed, J S Reis-Filho1 & I O Ellis.
Histopathology 2008, 52, 67–81.
More Details
|
-
Title:
Pattern of detection of locoregional recurrence in breast cancer: the Edinburgh experience.
Date:
July 2008
Authors:
Montgomery DA, Krupa K, Jack WJL, Kerr GR, Kunkler IH, Thomas J, Dixon JM.
British Journal of Cancer 2007; 96:1802-1807.
More Details
|
-
Title:
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Date:
July 2008
Authors:
Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH.
Lancet 2007; 370: 485-492.
More Details
|
-
Title:
Double-Blind, Randomized Placebo-Controlled Trial of Fulvestrant Compared With Exemestane After Prior Non-Steroidal Aromstase Inhibitor Therapy in Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer: Results from EFECT
Date:
April 2008 (ahead of print, March 3, 2008, jco.ascopubs.org)
Authors:
Stephen Chia, William Gradishar, Louis Mauriac et al.
Journal Clin Oncol, Vol. 26, Nr. 10
More Details
|
-
Title:
FECS NEWSLETTER
Date:
October 2005
Authors:
Scientific Editor - Dr. Razvan Popescu
ECCO 13 and a new direction for FECS
By Prof. Harry Bartelink, President, Federation of European Cancer Societies (FECS)
and Chairman of ECCO 13
Highlights from the ECCO 13 breast cancer sessions
Non-Colorectal cancer highlights at ECCO 13
Colorectal cancer highlights at ECCO 13
Highlights from the ECCO 13 genito-urinary sessions
Translational research highlights
Lung cancer highlights
Highlights from the ECCO 13 Nursing Programme
By Carol R. Krcmar, RN, MN, Member EONS Editorial Team
EORTC trials presented at ECCO 13
By Alexander M. M. Eggermont, EORTC President
TRANSBIG / MINDACT clinical trial: where are we?
By Nuria Decker, TRANSBIG Project Manager
Flims Alumni Club (FAC)
By Razvan Popescu, M.D., President Flims Alumni Club
FECS-ECCO Patients’ Programme
FECS NEWS
More Details
|
-
Title:
FECS NEWSLETTER
Date:
July 2005
Authors:
Scientific Editor - Dr. Razvan Popescu
Towards Reducing Disparity in Cancer Treatment
By Peter Boyle, Ph.D. Director, International Agency for Research on Cancer
Multidisciplinary treatment of locally advanced lung cancer
By Rafael Rosell, M.D. and Francoise Mornex, M.D., Ph.D.
Gynaecologic oncology in the age of molecular medicine
By Dirk G. Kieback, M.D., Ph.D.
JOURNAL DIGEST
EONS survey reveals nurses’ concerns
By Jan Foubert, Ph.D. President EONS
Recent FECS activities in…
More Details
|
-
Title:
FECS NEWSLETTER
Date:
April 2005
Authors:
Scientific Editor - Dr. Razvan Popescu
Breast conserving surgery — pioneer of multidisciplinary treatment
By Umberto Veronesi, M.D., Scientific Director, European Institute of Oncology
Locally-advanced rectal cancer — a multidisciplinary approach
By Gina Brown M.D., Rob Glynne-Jones M.D. and Lars Påhlman M.D., Ph.D.
Pathways to progress in cancer research
By Suzanne A. Eccles Ph.D., EACR Executive
Chemotherapy for advanced lung cancer
F.H. Blackhall & N. Thatcher
Cutaneous malignant melanoma in Europe
E. de Vries & J.W. Coebergh
Different signaling pathways regulate VEGF and IL-8 expression in breast
cancer: implications for therapy
D. Chelouche-Lev et al.
Expression of heat-shock protein Hsp60 correlated with the apoptotic index
and patient prognosis in human oesophageal squamous cell carcinoma
A. Faried et al.
EORTC actions to facilitate Translational Research in EORTC trials
By Alexander Eggermont M.D., Ph.D., President EORTC
A new model for oncology in Europe
By Stuart Bell Ph.D., FECS Communications Manager
More Details
|
-
Title:
FECS NEWSLETTER
Date:
January 2005
Authors:
Scientific Editor - Dr. Razvan Popescu
Introduction - Razvan Popescu
An invitation to ECCO 13
By Harry Bartelink, FECS President
Highlights from the 2004 ESMO congress
By Dirk Schrijvers M.D., Chairman ESMO Educational Committee
Highlights from the ESTRO 23 congress (24 – 28 October 2004)
By Stephan Bodis M.D., Chair Scientific Committee ESTRO 23
Treatment-induced bone loss: results of a European survey
By Jan Foubert Ph.D., EONS President.
Advances in treatment for glioblastoma multiforme
By Carmine Carapella M.D., EANO President.
FECS Recent Political Activities
More Details
|
-
Title:
FECS NEWSLETTER
Date:
October 2004
Authors:
Scientific Editor - Dr. Razvan Popescu
Introduction - Razvan Popescu
European Journal of Cancer – Your journal
By John Smyth, M.D.- Editor-in-Chief of EJC
BioCare: Molecular Imaging for Biologically Optimised Cancer Therapy
By Sharok Kimiaei, Ph.D. and Anders Brahme, Ph.D. - on behalf of ESTRO
Changes and developments at ECL
By Bruno Meili, President of the Association of European Cancer Leagues
The European School of Oncology
By Alberto Costa, M.D. and Antonella Surbone, M.D.
ESMO’s New Direction in Supportive and Palliative Care: Part 2
By Nathan I. Cherny, MBBS FRACP and Raphael Catane, M.D.
FLIMS 2005
Application Announcement
More Details
|
-
Title:
FECS NEWSLETTER
Date:
July 2004
Authors:
Scientific Editor - Dr. Razvan Popescu
Introduction - Razvan Popescu
The 12th ESSO Congress proves that cancer surgery is multidisciplinary
By Peter Naredi
EU Directive 2004/23/EC: "Towards standards of quality and safety for human tissues and cells in Europe"
Fiona McDonald,Ineke Slaper-Cortenbach and Alvaro Urbano-Ispizua on behalf of the Joint Accreditation
Committee of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation
(JACIE)
"Nutrition in Oncology Educational Programme" (NOEP)launched for nurses
By Karin Ahlberg,EONS Board Member
ESMO's new direction in Supportive and Palliative Care:Part 1
By Nathan I Cherny and Raphael Catane
EACR-18:the best of European cancer research
By Hans Grunicke,EACR-18 Conference Chair and President of EACR
FECS Activities
TRANSBIG: a new direction in breast cancer research
More Details
|
|
|
-
Title:
The Hamburg Statement
Date:
Hamburg, 20 March 2004
Authors:
Jacek Jassem,
Mary Buchanan,
Luigi Cataliotti,
Stella Kyriakides,
Emiel Rutgers.
Clinicians, scientists, and health care consumers representing 3,557 participants used a computerised voting system in plenary session to formulate the Hamburg Statement.
More Details
|
|
|
-
Title:
A European strategy in the fight against breast cancer.
European Parliament calls for mammography screening and breast centres
Date:
Strasbourg, 5 June 2003
Authors:
Karin Jöns
In the European Union 216 000 women are diagnosed with breast cancer every year, and there are 79 000 deaths from breast cancer in women. Yet 25 000 women could be saved if all women were to be offered high-quality screening.
More Details
|
-
Title:
European parliament to vote on breast cancer initiative report
Date:
February 19 2003
Authors:
Europa Donna and European Parliament Collaborate on Investigating Standards of Care
EUROPA DONNA - The European Breast Cancer Coalition and its National Fora are collaborating with Karin Jöns, Member of the European Parliament, to collect data on the extent of coverage offered by national health insurance programmes in breast cancer care in the European Union and in EU candidate countries.
More Details
|
-
Title:
Improving clinical skills in early breast cancer
Date:
February 3-7 2003
Authors:
Dr. Gatzemeier
Grand Hotel Union, Ljubljana, Slovenia
For the first time the European Society of Mastology (EUSOMA) , the European Society of Surgical Oncology (ESSO) and the European School of Oncology (ESO) launched a one week, intensive residential course on “Improving clinical skills in early breast cancer “ as a joint venture .
More Details
|
|
|
-
Title:
Impact of new technologies in partial breast irradiation
Date:
01 April 2003
Authors:
Lartigau E.*, Marsiglia H.‡, Schiappacasse L.‡
*Radiotherapy Department, Centre Oscar Lambret, Lille, France
‡Radiotherapy Department, Institut Gustave-Roussy, Paris, France
More Details
|
-
Title:
Correlation between the Biofield Diagnostic System Test and Ki-67 Labeling Index to Identify Highly Proliferating Palpable Breast Lesions
Date:
December 2002
Authors:
W. Gatzemeier, J. Cuzick, M. Scelsi, K. Galetti, L. Villani, C. Tinterri, L. Regolo, A. Costa
San Antonio Breast Cancer Symposium 2002
More Details
|
-
Title:
Utility of biopotentials measured with the Biofield Diagnostic System for distinguishing malignant from benign lesions and proliferative from nonproliferative benign lesions
Date:
December 2002
Authors:
Sacchini V, Gatzemeier W, Costa A, Merson M, Bonanni B, Gennaro M, Zandonini G, Gennari R, Holland R, Schreer I, Vanel D
San Antonio Breast Cancer Symposium 2002
More Details
|
-
Title:
An economic evaluation of the optimal workload in treating surgical patients in a breast Unit
Date:
23 October 2002
Authors:
E. Pagano; A. Ponti; E. Gelormino; F. Merletti; M. P. Mano
EJC 39, 2003, Issue 5 pp 748-754
Reproduced with permission from Elsevier.
More Details
|
| |
|
|
|